514 The Discovery of CGEN-15001T, a Novel Immune Checkpoint Target for Immunotherapy in Cancer

G. Cojocaru, Z. Levine, A. Toporik, L. Dassa, S. Nemzer, O. Levy

Open source

DOI
10.1016/s0959-8049(12)72311-0
Published
2012-11
Container
European Journal of Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0959-8049-12-72311-0,
  title = {514 The Discovery of CGEN-15001T, a Novel Immune Checkpoint Target for Immunotherapy in Cancer},
  author = {G. Cojocaru and Z. Levine and A. Toporik and L. Dassa and S. Nemzer and O. Levy},
  year = {2012},
  journal = {European Journal of Cancer},
  doi = {10.1016/s0959-8049(12)72311-0},
  url = {https://doi.org/10.1016/s0959-8049(12)72311-0}
}

RIS

TY  - JOUR
TI  - 514 The Discovery of CGEN-15001T, a Novel Immune Checkpoint Target for Immunotherapy in Cancer
AU  - G. Cojocaru
AU  - Z. Levine
AU  - A. Toporik
AU  - L. Dassa
AU  - S. Nemzer
AU  - O. Levy
PY  - 2012
JO  - European Journal of Cancer
DO  - 10.1016/s0959-8049(12)72311-0
UR  - https://doi.org/10.1016/s0959-8049(12)72311-0
ER  - 

APA

Cojocaru, G., Levine, Z., Toporik, A., Dassa, L., Nemzer, S., & Levy, O. (2012). 514 The Discovery of CGEN-15001T, a Novel Immune Checkpoint Target for Immunotherapy in Cancer. European Journal of Cancer. https://doi.org/10.1016/s0959-8049(12)72311-0

Source records